Johnson & Johnson (JNJ) Buildings (2010 - 2021)
Johnson & Johnson's (JNJ) quarterly Buildings came in at $12.5 billion in Q1 2021, up 5.26% year-on-year from $11.9 billion in Q1 2020, and up 5.26% quarter-over-quarter from $11.9 billion in Q4 2019.
Johnson & Johnson (JNJ) Buildings (2010 - 2021) Analysis & Trends
Johnson & Johnson has disclosed Buildings across 10 years of filings, most recently posting $12.5 billion for Q1 2021.
- Buildings for Q1 2021 came in at $12.5 billion, up 5.26% year-over-year; the trailing twelve-month figure through Jan 2021 was $12.5 billion (up 5.26% YoY), and the FY2021 annual result was $12.5 billion, up 5.26% from the prior year.
- Buildings came in at $12.5 billion for Q1 2021 at Johnson & Johnson, up from $11.9 billion in the prior quarter.
- In the past five years, Buildings ranged from a high of $12.5 billion in Q1 2021 to a low of $10.1 billion in Q1 2017.
- The 4-year median for Buildings is $11.2 billion (2017), against an average of $11.4 billion.
- Across the five-year window, Buildings increased 11.16% in 2017 and retreated 0.57% in 2018, its largest moves.
- Johnson & Johnson's Buildings stood at $11.2 billion in 2017, then fell by 0.57% to $11.2 billion in 2018, then climbed by 6.27% to $11.9 billion in 2019, then climbed by 5.26% to $12.5 billion in 2021.
- The last three Buildings figures came in at $12.5 billion (Q1 2021), $11.9 billion (Q4 2019), and $11.2 billion (Q4 2018), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Gsk | 92,316,836.42 Bn | 92,316,831.46 Bn | 7.76 Bn |
| 2 | Eli Lilly | 983.57 Bn | 978.29 Bn | 16.22 Bn |
| 3 | Johnson & Johnson | 553.56 Bn | 531.50 Bn | 15.96 Bn |
| 4 | AbbVie | 383.35 Bn | 374.00 Bn | 10.78 Bn |
| 5 | Merck | 281.71 Bn | 276.06 Bn | 12.09 Bn |
| 6 | Amgen | 182.20 Bn | 170.16 Bn | 5.87 Bn |
| 7 | Gilead Sciences | 153.71 Bn | 145.98 Bn | 5.52 Bn |
| 8 | Pfizer | 143.75 Bn | 130.98 Bn | -1.21 Bn |
| 9 | Bristol Myers Squibb | 109.71 Bn | 99.25 Bn | 8.07 Bn |
| 10 | Novartis Ag | 108.28 Bn | 107.60 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 3, 2021 | 12.50 Bn |
| Dec 29, 2019 | 11.88 Bn |
| Dec 30, 2018 | 11.18 Bn |
| Dec 31, 2017 | 11.24 Bn |
| Jan 1, 2017 | 10.11 Bn |
| Jan 3, 2016 | 9.83 Bn |
| Dec 28, 2014 | 10.05 Bn |
| Dec 29, 2013 | 10.42 Bn |
| Dec 30, 2012 | 10.05 Bn |
| Jan 1, 2012 | 9.39 Bn |
| Jan 2, 2011 | 9.08 Bn |
| Jan 3, 2010 | 8.86 Bn |